Product Images Rizatriptan Benzoate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Rizatriptan Benzoate NDC 50090-3367 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label Image - lbl500903367
Figure 1: Estimated Probability of Achieving an Initial Headache Response by 2 Hours in Pooled Studies 1, 2, 3, and 4†† - rizatriptan fig1
This is a graph displaying the probability of achieving an initial headache response within 2 hours after treatment with placebo, 5mg and 10mg doses of rizatriptan benzoate. The graph displays estimates based on pooled data from 4 outpatient clinical trials (Studies 1, 2, 3, and 4). The data only includes patients who achieved headache response or had mild/no pain within 2 hours after treatment. Patients who did not achieve headache response or were taking additional treatment were excluded from the data.*
Figure 2: Estimated Probability of Patients Taking a Second Dose of Rizatriptan Benzoate Tablets or Other Medication for Migraines Over the 24 Hours Following the Initial Dose of Study Treatment in Pooled Studies 1, 2, 3, and 4††† - rizatriptan fig2
This is a Figure 2 plot representing the estimated probability that patients will take a second dose of Rizatriptan Benzoate tablets or other medication for migraines within 24 hours following the initial dosage of the study treatment. The plot is based on data from different clinical trials (Studies 1, 2, 3, and 4) and shows that patients who took Rizatriptan Benzoate 5mg had a probability of 190% of taking a second dose while those who took 10mg had a probability of 180%. Patients not using additional treatments were excluded after 24 hours, and re-medication could not be done within 2 hours.*
Figure 5: Observed Percentage of Patients Reporting No Headache Pain by 2 Hours Post-Dose in Study 7 - rizatriptan fig3
Chemical Structure - rizatriptan str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.